CTOs on the Move


 
Cybrdi is a Frederick, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cybrdi.com
  • 401 Rosemont Ave
    Frederick, MD USA 21701
  • Phone: 301.644.3901

Executives

Name Title Contact Details

Similar Companies

Canadian Hospital Specialties

Canadian Hospital Specialties Ltd is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Institute for Functional Medicine

Institute for Functional Medicine is a Gig Harbor, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Camber Spine

Innovative spine and medical technology company Camber Spine is dedicated to creating surgeon-designed solutions in MIS and minimally disruptive access for the treatment of complex spinal pathology. Incorporating state-of-the-art manufacturing, 3-D printing, and an acute sensitivity to patient anatomy, we are making quantum leaps in the spinal fusion market. Our patented OLIF system and procedure – with its less complicated, simpler approach to treating complex spinal pathologies – is poised to change the way spine care is delivered. Camber Spine now has 20 products with 510(k) clearances and over 28 active or issued patents, including two award-winning, highly innovative and IP protected device platforms that support faster spinal fusion and recovery: ENZA® (MIS Integrated Interbody) spinal fusion implants; and SPIRA® OA (Open Architecture 3D printed) spinal fusion and orthopedic implants. Our 27,000 sq. ft. state-of-the-art facility just outside Philadelphia features meeting facilities, office spaces, a mechanical test lab with full prototype shop and an expanded double cadaver lab.

Professional Hospital Supply

PHS broke ground in August 2003 on a 212,000-square-foot facility on almost 12 acres in Fairfield, Calif. Occupancy was anticipated for late 2003 or early 2004.

Spirox

Spirox is a Menlo Park, CA-based medical device company. The company intends to use the funds to complete development, seek US marketing authorization, and initiate product commercialization.